 |
市場調査レポート
商品コード
1461628
2DPA-1の世界市場規模、シェア、成長分析、用途別、最終用途別-産業予測、2024～2031年Global 2DPA-1 Market Size, Share, Growth Analysis, By Application(Pharmaceuticals, Agrochemicals), By End Use(Healthcare, Textile & Dye) - Industry Forecast 2024-2031 |
||||||
| 2DPA-1の世界市場規模、シェア、成長分析、用途別、最終用途別-産業予測、2024～2031年 |
|
出版日: 2024年04月02日
発行: SkyQuest
ページ情報: 英文 184 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の2DPA-1市場規模は、2022年に6,176億1,000万米ドルと評価され、2023年の6,410億8,000万米ドルから2031年には8,639億5,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは3.80％で成長する展望です。
汎用性の高い化合物であるDAPAは、医薬品合成、染料生産、さまざまな工業プロセスにおいて広範な用途を見出しています。2-ジフェニルアセチル-1,3-インダンジオンとしても知られる革新的な化合物である2DPA-1の世界市場は、そのユニークな特性を活かして、この合成化合物に対する多様な産業ニーズに対応しています。需要の高まりに対応するため、世界の2DPA-1市場は、主に医薬、農薬、特殊化学合成の化学中間体として、幅広い用途にこの化合物を供給することに注力しています。さらに、染料、顔料、パーソナルケア製品の製造においても重要な役割を果たしており、老化防止、抗炎症、抗酸化機能が高く評価されています。拡大する世界の2DPA-1市場は、多方面にわたる革新的ソリューションの需要増に対応するため、業界関係者に有利な機会を提供しています。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模の推定
- 市場の危機と限界
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
2DPA-1の世界市場：用途別
- 市場概要
- 医薬品
- 農薬
- 化粧品
- その他
2DPA-1の世界市場：最終用途別
- 市場概要
- 医療
- 繊維・染料
- その他
2DPA-1の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Siemens AG（ドイツ）
- GE Healthcare（米国）
- Philips Healthcare（オランダ）
- Canon Medical Systems Corporation（日本）
- Hitachi, Ltd.（日本）
- Toshiba Medical Systems Corporation（日本）
- Koninklijke Philips N.V.（オランダ）
- Fujifilm Holdings Corporation（日本）
- Carestream Health, Inc.（米国）
- Esaote SpA（イタリア）
- Samsung Medison Co., Ltd.（韓国）
- Hologic, Inc.（米国）
- Mindray Medical International Limited（中国）
- Agfa-Gevaert NV（ベルギー）
- Shimadzu Corporation（日本）
- CurveBeam LLC（米国）
- Planmed Oy（フィンランド）
- Medtronic plc（アイルランド）
- Varian Medical Systems, Inc.（米国）
- Epiroc AB（スウェーデン）
- Elekta AB（スウェーデン）
Global 2DPA-1 Market size was valued at USD 617.61 billion in 2022 and is poised to grow from USD 641.08 billion in 2023 to USD 863.95 billion by 2031, growing at a CAGR of 3.80% during the forecast period (2024-2031).
The versatile compound DAPA finds extensive application in pharmaceutical synthesis, dye production, and various industrial processes. The global market for 2DPA-1, an innovative chemical compound also known as 2-diphenylacetyl-1,3-indandione, caters to the diverse industrial needs for this synthetic compound with its unique properties. Serving to meet the rising demand, the global 2DPA-1 market focuses on supplying this compound for a broad spectrum of applications, primarily as a chemical intermediate in pharmaceutical, agrochemical, and specialty chemical synthesis. Moreover, it plays a vital role in dye, pigment, and personal care product manufacturing, where its anti-aging, anti-inflammatory, and antioxidant features are highly valued. The expanding global 2DPA-1 market offers lucrative opportunities for industry players to meet the increasing demand for innovative solutions across multiple sectors.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global 2DPA-1 Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global 2DPA-1 Market Segmental Analysis
Global 2DPA-1 Market is segmented on the basis of application, end user and region. By application, the market is segmented into pharmaceuticals, agrochemicals, cosmetics, and others. By end user, the market is segmented into healthcare, textile & dye, others. By region, the market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global 2DPA-1 Market
The pharmaceutical sector tirelessly seeks fresh and inventive drug prospects to tackle diverse health issues. The distinctive therapeutic attributes of 2DPA-1, encompassing its anti-inflammatory, anti-cancer, and antiviral effects, propel its integration into drug exploration and advancement efforts, consequently fostering a substantial Compound Annual Growth Rate (CAGR) for the worldwide 2DPA-1 market throughout the projected timeframe.
Restraints in the Global 2DPA-1 Market
The arrival of new players in both regional and global markets has the potential to intensify competition, posing a significant threat to established entities. Enhanced product portfolios introduced by competitors can escalate the stakes for existing players, further heightening the competitive landscape.
Market Trends of the Global 2DPA-1 Market
The complexity and expense involved in producing 2DPA-1 could hinder its broad acceptance across industries, potentially restricting its market expansion. Elevated production costs might constrain the availability and affordability of 2DPA-1, thereby impeding its market growth and resulting in a comparatively lower Compound Annual Growth Rate (CAGR) for the global 2DPA-1 market in the projected timeframe.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global 2DPA-1 Market by Application
- Market Overview
- Pharmaceuticals
- Agrochemicals
- Cosmetics
- Others
Global 2DPA-1 Market by End Use
- Market Overview
- Healthcare
- Textile & Dye
- Others
Global 2DPA-1 Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Siemens AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hitachi, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Toshiba Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Carestream Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Esaote SpA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Samsung Medison Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agfa-Gevaert NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CurveBeam LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Varian Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Epiroc AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
